Data / Drug companies / Dextromethorphan hbr
Dextromethorphan hbr: 22 companies and 34 products in the FDA NDC directory
Dextromethorphan hbr is listed in the FDA National Drug Code Directory by 22 companies, with 34 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are liquid; capsule, liquid filled; solution, and the newest product started marketing on August 31, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 22
- Products
- 34
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 2
- Routes
- Oral
- Brand names
- Cough Relief, Adult Long Lasting Cough Relief, Giltuss Honey DM Cough, Cough Relief Adult, Father Johns Medicine, Childrens Giltuss Honey DM Cough, RoboCough, CVS Daytime Cough Relief Chews - Citrus Punch
- openFDA record search
- api.fda.gov
Companies that list dextromethorphan hbr
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Gil Pharmaceutical Corp | 4 | solution; syrup | Over the counter monograph drugs | August 9, 2023 |
| Raritan Pharmaceuticals Inc | 3 | syrup; liquid | Over the counter monograph drugs | April 24, 2023 |
| CVS Woonsocket Prescription Center, Incorporated | 2 | chewable gel | Over the counter monograph drugs | March 4, 2025 |
| DXM Pharmacuetical, Inc. | 2 | liquid; tablet | Over the counter monograph drugs | October 1, 2023 |
| Dextrum Laboratories, Inc | 2 | solution; liquid | Over the counter monograph drugs | June 22, 2020 |
| Humanwell PuraCap Pharmaceutical (Wuhan), Ltd. | 2 | capsule, liquid filled | Over the counter monograph drugs | December 10, 2014 |
| Shield Pharmaceuticals Corp | 2 | capsule, liquid filled | Over the counter monograph drugs | August 7, 2026 |
| Valu Merchandisers Company | 2 | liquid | Over the counter monograph drugs | March 15, 2024 |
| Walgreen Company | 2 | capsule, liquid filled; chewable gel | Over the counter monograph drugs | April 30, 2026 |
| Amerisource Bergen | 1 | liquid | Over the counter monograph drugs | June 24, 2024 |
| Bionpharma Inc. | 1 | capsule, liquid filled | Over the counter monograph drugs | August 31, 2026 |
| CVS Pharmacy | 1 | liquid | Over the counter monograph drugs | May 2, 2022 |
| Chain Drug Consortium, LLC | 1 | liquid | Over the counter monograph drugs | May 23, 2019 |
| Chain Drug Marketing Association | 1 | liquid | Over the counter monograph drugs | July 31, 2015 |
| Chain Drug Marketing Association, Inc. | 1 | liquid | Over the counter monograph drugs | July 31, 2024 |
| Dolgencorp, Inc. (dollar General & Rexall) | 1 | liquid | Over the counter monograph drugs | August 31, 2015 |
| Humco Holding Group, Inc. | 1 | liquid | Over the counter monograph drugs | June 17, 2019 |
| Oakhurst Company | 1 | liquid | Over the counter monograph drugs | June 17, 2019 |
| Pharmadel LLC | 1 | liquid | Over the counter monograph drugs | September 3, 2020 |
| Rugby Laboratories | 1 | capsule, liquid filled | Over the counter monograph drugs | September 4, 2021 |
| The Procter & Gamble Manufacturing Company | 1 | liquid | Over the counter monograph drugs | December 21, 2020 |
| Topco Associates LLC | 1 | liquid | Over the counter monograph drugs | March 31, 2016 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Liquid | 16 | 47.1% |
| Capsule, liquid filled | 7 | 20.6% |
| Solution | 4 | 11.8% |
| Chewable gel | 3 | 8.8% |
| Syrup | 3 | 8.8% |
| Tablet | 1 | 2.9% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 34 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Sigma-1 Agonist | 34 |
| Uncompetitive N-methyl-D-aspartate Receptor Antagonist | 34 |
| Antihistamine | 1 |
| Expectorant | 1 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.